Exploring the Use of Transdermal Methylphenidate to Reduce Fall Risk in Patients With Dementia.

NCT01825577 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

14

Enrollment

OTHER

Sponsor class

Stopped Administrative Reasons

Conditions

Dementia
Accidental Falls
Apathy

Interventions

DRUG: Transdermal Methylphenidate

Sponsor

St. Louis University